Gaurav Kharya/LinkedIn
Jun 24, 2026, 16:49
Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
Gaurav Kharya, Director, Dept. of Bone Marrow Transplant and Cellular Therapy at Indraprastha Apollo Hospitals, shared a post on LinkedIn:
“Some issues cannot wait.
Access to safe blood for people who depend on regular transfusions is one of them-because delays can have life-threatening consequences.
My article in The Week looks at why ensuring timely and safe blood access remains critical, and why sustained attention and action are needed for those who rely on it every day.
Indraprastha Apollo Hospitals, New Delhi Cellogen Therapeutics
Bridging the gaps: Safe blood, lifesaving care, and a cure for sickle cell disease – The Week.”
Stay updated with Hemostasis Today.
-
Sep 29, 2026, 19:00Caitlin Raymond: Can Artificial Blood Solve Blood Supply Shortages?
-
Sep 29, 2026, 18:51Chaza Alaji: Dyslipidemia, Thrombosis and the DIC Diagnostic Trap
-
Sep 29, 2026, 17:31Rajnikant Patel: Bridging Ayurvedic Concepts and Modern Toxin-Mediated Disease
-
Sep 29, 2026, 17:13Nicholas Lang։ A Meaningful Case of Immune Thrombocytopenia
-
Sep 29, 2026, 16:55Ayatullah Gamal Wahab: When the CBC Lies
-
Sep 29, 2026, 16:35Jonathan Douxfils: Navigating the VTE Risk Continuum in Reproductive Medicine
-
Sep 29, 2026, 16:35Chaima Rajeh: Types of Anemia and Their Laboratory Features
-
Sep 29, 2026, 16:27Scott Isaacs: How GLP-1 RAs Target Systemic Inflammation to Drive Cardio, Autoimmune, and Gut Health
-
Sep 29, 2026, 16:21Yitshak Kreiss: From Treating Patients to Defining the Standard of Knowledge